Our Structured CRO Advisory Model for Early-Stage Biotech Companies

How the Advisory Model Works

A structured control system operating across key regulatory milestones.

Level 1 - Clinical Execution Readiness

Objective

Assess whether the organization is operationally and strategically prepared to enter clinical development.

• Structured CRO Readiness Report

• CRO Readiness Score

• Clinical Entry Budget Benchmark

• CRO Landscape & Pre-selection List

• Executive Strategic Debrief Session

• Governance & Decision Structure

• Clinical Strategy Positioning

• Financial Exposure Before Vendor Commitment

• Outsourcing Approach

• Risk Exposure Mapping

Focus areas

Outputs

Prior to IND/CTA submission, investor diligence, and before committing to CRO strategy for the first clinical trial.

Level 2 - Clinical Transition Structuring

Objective

Establish a structured and strategically aligned CRO selection framework prior to financial commitment.

• CRO Matching & Shortlisting

• Protocol-Aligned Preliminary Budget Benchmark

• RFP Structuring & Guidance

• Governance & Contractual Boundary Framework

• Executive Transition Alignment Session

• Governance & Decision Framework

• Clinical Development Alignment

• Budget & Financial Positioning

• CRO Engagement Strategy

• Negotiation Readiness

• Risk Exposure Mapping

Focus areas

Outputs

During IND/CTA preparation and prior to formal CRO proposal evaluation.

Level 3 - Budget & Vendor Evaluation

Objective

Ensure CRO selection and budget structures are aligned with strategic and financial sustainability.

• RFP Review and Proposal Comparison Report

• Budget Negotiation Strategy

• Bid Defense Strategy

• Contractual & Financial Risk Red Flag Summary

• Executive CRO Decision Brief

• Proposal & Budget Architecture

• Vendor Capability Assessment & Operational Fit

• Clinical & Protocol Alignment Validation

• Financial & Contractual Risk Assessment

• Negotiation Positioning & Governance Boundaries

Focus areas

Outputs

Surrounding IND/CTA submission and CRO evaluation & contract negotiation phase.

Level 4 - Ongoing CRO Oversight and Strategic Trial Governance

Objective

Maintain strategic control, financial discipline, and anticipatory risk management throughout trial execution.

• Periodic strategic oversight reports

• Budget exposure and financial visibility

• Risk management recommendations

• Independent decision-support briefings

• Budget performance and financial exposure monitoring

• Change order pattern analysis

• Milestone and execution risk anticipation

• Critical inflection points identification and mitigation

Focus areas

Outputs

During active clinical trial execution.

Where does your organization stand today?

Determine the appropriate level of structured control before advancing to the next clinical milestone.